Page last updated: 2024-08-23
simvastatin and hr 780
simvastatin has been researched along with hr 780 in 2 studies
Research
Studies (2)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Makita, S; Oshima, K; Wajima, T | 2 |
Other Studies
2 other study(ies) available for simvastatin and hr 780
Article | Year |
---|---|
Direct vascular effects of HR780, a novel 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor.
Topics: Animals; Aorta, Thoracic; Cell Division; Cell Movement; Cells, Cultured; Dose-Response Relationship, Drug; Endothelial Cells; Fetal Blood; Hydroxymethylglutaryl-CoA Reductase Inhibitors; L-Lactate Dehydrogenase; Male; Mevalonic Acid; Muscle, Smooth, Vascular; Platelet-Derived Growth Factor; Pravastatin; Probucol; Pyridines; Rabbits; Simvastatin; Swine; Xanthine; Xanthine Oxidase | 2003 |
Effects of HR780, a novel 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, in Watanabe heritable hyperlipidemic rabbits and cholesterol-fed rabbits.
Topics: Animals; Animals, Genetically Modified; Bile; Cholesterol; Cholesterol, Dietary; Disease Models, Animal; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Japan; Lipids; Liver; Male; Pyridines; Rabbits; Simvastatin | 2004 |